Medical Care
Global Drugs for Osteoarthritis Pain Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 223271
- Pages: 106
- Figures: 107
- Views: 41
The global Drugs for Osteoarthritis Pain market size was US$ 10350 million in 2024 and is forecast to a readjusted size of US$ 15380 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
The global Drugs for Osteoarthritis Pain market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
Oral
Injection
External
By Application: (Core Demand Driver vs Emerging Opportunity)
Medical Care
Personal Care
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Pfizer in Europe)
- Emerging Product Trends: Oral adoption vs. Injection premiumization
- Demand-Side Dynamics: Medical Care growth in China vs. Personal Care potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Mid East & Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drugs for Osteoarthritis Pain market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Injection in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Personal Care in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drugs for Osteoarthritis Pain value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
The global Drugs for Osteoarthritis Pain market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
Oral
Injection
External
By Application: (Core Demand Driver vs Emerging Opportunity)
Medical Care
Personal Care
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Pfizer in Europe)
- Emerging Product Trends: Oral adoption vs. Injection premiumization
- Demand-Side Dynamics: Medical Care growth in China vs. Personal Care potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Mid East & Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drugs for Osteoarthritis Pain market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Injection in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Personal Care in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drugs for Osteoarthritis Pain value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2025)
2.4 Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.2 Europe Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.3 China Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.4 Japan Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.5 Mid East & Africa Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2020-2025)
3.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drugs for Osteoarthritis Pain Representative Players
4 Breakdown Data by Application
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drugs for Osteoarthritis Pain Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2020-2025)
5.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
5.4 Global Drugs for Osteoarthritis Pain Market Concentration Analysis
5.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2024
5.5 Global Key Players of Drugs for Osteoarthritis Pain Head office and Area Served
5.6 Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
5.7 Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.1.2.2 North America Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.1.3.2 North America Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.2.2.2 Europe Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.2.3.2 Europe Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.3.2.2 China Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.3.3.2 China Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.4.2.2 Japan Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.4.3.2 Japan Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Mid East & Africa Market: Players, Segments and Downstream
6.5.1 Mid East & Africa Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.5.2 Mid East & Africa Market Size by Type
6.5.2.1 Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.5.2.2 Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.5.3 Mid East & Africa Market Size by Application
6.5.3.1 Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.5.3.2 Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.5.4 Mid East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
7.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.1.5 Pfizer Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Details
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
7.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.2.5 Johnson & Johnson Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Details
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
7.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.3.5 GlaxoSmithKline Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
7.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.4.5 Bayer Recent Development
7.5 Eli Lilly
7.5.1 Eli Lilly Company Details
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
7.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.5.5 Eli Lilly Recent Development
7.6 Novartis
7.6.1 Novartis Company Details
7.6.2 Novartis Business Overview
7.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
7.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.6.5 Novartis Recent Development
7.7 Sanofi
7.7.1 Sanofi Company Details
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
7.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.7.5 Sanofi Recent Development
7.8 Horizon Pharma
7.8.1 Horizon Pharma Company Details
7.8.2 Horizon Pharma Business Overview
7.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
7.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.8.5 Horizon Pharma Recent Development
7.9 Abbott
7.9.1 Abbott Company Details
7.9.2 Abbott Business Overview
7.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
7.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.9.5 Abbott Recent Development
7.10 Mylan
7.10.1 Mylan Company Details
7.10.2 Mylan Business Overview
7.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
7.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.10.5 Mylan Recent Development
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Company Details
7.11.2 Daiichi Sankyo Business Overview
7.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
7.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.11.5 Daiichi Sankyo Recent Development
7.12 TEVA
7.12.1 TEVA Company Details
7.12.2 TEVA Business Overview
7.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
7.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.12.5 TEVA Recent Development
7.13 Almatica Pharma
7.13.1 Almatica Pharma Company Details
7.13.2 Almatica Pharma Business Overview
7.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
7.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.13.5 Almatica Pharma Recent Development
7.14 Astellas Pharma
7.14.1 Astellas Pharma Company Details
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
7.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.14.5 Astellas Pharma Recent Development
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Company Details
7.15.2 Tide Pharmaceutical Business Overview
7.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
7.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.15.5 Tide Pharmaceutical Recent Development
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Company Details
7.16.2 Iroko Pharmaceuticals Business Overview
7.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
7.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.16.5 Iroko Pharmaceuticals Recent Development
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Company Details
7.17.2 Hengrui Pharmaceutical Business Overview
7.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
7.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.17.5 Hengrui Pharmaceutical Recent Development
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Company Details
7.18.2 Abiogen Pharma Business Overview
7.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
7.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.18.5 Abiogen Pharma Recent Development
8 Drugs for Osteoarthritis Pain Market Dynamics
8.1 Drugs for Osteoarthritis Pain Industry Trends
8.2 Drugs for Osteoarthritis Pain Market Drivers
8.3 Drugs for Osteoarthritis Pain Market Challenges
8.4 Drugs for Osteoarthritis Pain Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2025)
2.4 Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.2 Europe Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.3 China Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.4 Japan Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
2.5.5 Mid East & Africa Drugs for Osteoarthritis Pain Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2020-2025)
3.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drugs for Osteoarthritis Pain Representative Players
4 Breakdown Data by Application
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drugs for Osteoarthritis Pain Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2020-2025)
5.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
5.4 Global Drugs for Osteoarthritis Pain Market Concentration Analysis
5.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2024
5.5 Global Key Players of Drugs for Osteoarthritis Pain Head office and Area Served
5.6 Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
5.7 Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.1.2.2 North America Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.1.3.2 North America Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.2.2.2 Europe Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.2.3.2 Europe Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.3.2.2 China Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.3.3.2 China Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.4.2.2 Japan Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.4.3.2 Japan Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Mid East & Africa Market: Players, Segments and Downstream
6.5.1 Mid East & Africa Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
6.5.2 Mid East & Africa Market Size by Type
6.5.2.1 Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.5.2.2 Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
6.5.3 Mid East & Africa Market Size by Application
6.5.3.1 Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.5.3.2 Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
6.5.4 Mid East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
7.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.1.5 Pfizer Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Details
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
7.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.2.5 Johnson & Johnson Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Details
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
7.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.3.5 GlaxoSmithKline Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
7.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.4.5 Bayer Recent Development
7.5 Eli Lilly
7.5.1 Eli Lilly Company Details
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
7.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.5.5 Eli Lilly Recent Development
7.6 Novartis
7.6.1 Novartis Company Details
7.6.2 Novartis Business Overview
7.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
7.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.6.5 Novartis Recent Development
7.7 Sanofi
7.7.1 Sanofi Company Details
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
7.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.7.5 Sanofi Recent Development
7.8 Horizon Pharma
7.8.1 Horizon Pharma Company Details
7.8.2 Horizon Pharma Business Overview
7.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
7.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.8.5 Horizon Pharma Recent Development
7.9 Abbott
7.9.1 Abbott Company Details
7.9.2 Abbott Business Overview
7.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
7.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.9.5 Abbott Recent Development
7.10 Mylan
7.10.1 Mylan Company Details
7.10.2 Mylan Business Overview
7.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
7.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.10.5 Mylan Recent Development
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Company Details
7.11.2 Daiichi Sankyo Business Overview
7.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
7.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.11.5 Daiichi Sankyo Recent Development
7.12 TEVA
7.12.1 TEVA Company Details
7.12.2 TEVA Business Overview
7.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
7.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.12.5 TEVA Recent Development
7.13 Almatica Pharma
7.13.1 Almatica Pharma Company Details
7.13.2 Almatica Pharma Business Overview
7.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
7.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.13.5 Almatica Pharma Recent Development
7.14 Astellas Pharma
7.14.1 Astellas Pharma Company Details
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
7.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.14.5 Astellas Pharma Recent Development
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Company Details
7.15.2 Tide Pharmaceutical Business Overview
7.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
7.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.15.5 Tide Pharmaceutical Recent Development
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Company Details
7.16.2 Iroko Pharmaceuticals Business Overview
7.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
7.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.16.5 Iroko Pharmaceuticals Recent Development
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Company Details
7.17.2 Hengrui Pharmaceutical Business Overview
7.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
7.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.17.5 Hengrui Pharmaceutical Recent Development
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Company Details
7.18.2 Abiogen Pharma Business Overview
7.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
7.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
7.18.5 Abiogen Pharma Recent Development
8 Drugs for Osteoarthritis Pain Market Dynamics
8.1 Drugs for Osteoarthritis Pain Industry Trends
8.2 Drugs for Osteoarthritis Pain Market Drivers
8.3 Drugs for Osteoarthritis Pain Market Challenges
8.4 Drugs for Osteoarthritis Pain Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drugs for Osteoarthritis Pain Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drugs for Osteoarthritis Pain Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drugs for Osteoarthritis Pain Revenue Share by Region (2020-2025)
Table 6. Global Drugs for Osteoarthritis Pain Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drugs for Osteoarthritis Pain Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Table 10. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Table 15. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drugs for Osteoarthritis Pain Application
Table 18. Global Drugs for Osteoarthritis Pain Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drugs for Osteoarthritis Pain Market Share by Players (2020-2025)
Table 20. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Table 21. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served
Table 24. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
Table 25. Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 29. North America Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 37. China Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 41. Japan Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 43. Mid East & Africa Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 44. Mid East & Africa Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 45. Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 46. Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Drugs for Osteoarthritis Pain Product
Table 50. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 55. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. GlaxoSmithKline Company Details
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 60. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Drugs for Osteoarthritis Pain Product
Table 65. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 70. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Osteoarthritis Pain Product
Table 75. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Drugs for Osteoarthritis Pain Product
Table 80. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Horizon Pharma Company Details
Table 83. Horizon Pharma Business Overview
Table 84. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 85. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 86. Horizon Pharma Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Drugs for Osteoarthritis Pain Product
Table 90. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Drugs for Osteoarthritis Pain Product
Table 95. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Daiichi Sankyo Company Details
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 100. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 101. Daiichi Sankyo Recent Development
Table 102. TEVA Company Details
Table 103. TEVA Business Overview
Table 104. TEVA Drugs for Osteoarthritis Pain Product
Table 105. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 106. TEVA Recent Development
Table 107. Almatica Pharma Company Details
Table 108. Almatica Pharma Business Overview
Table 109. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 110. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 111. Almatica Pharma Recent Development
Table 112. Astellas Pharma Company Details
Table 113. Astellas Pharma Business Overview
Table 114. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 115. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 116. Astellas Pharma Recent Development
Table 117. Tide Pharmaceutical Company Details
Table 118. Tide Pharmaceutical Business Overview
Table 119. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 120. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 121. Tide Pharmaceutical Recent Development
Table 122. Iroko Pharmaceuticals Company Details
Table 123. Iroko Pharmaceuticals Business Overview
Table 124. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 125. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 126. Iroko Pharmaceuticals Recent Development
Table 127. Hengrui Pharmaceutical Company Details
Table 128. Hengrui Pharmaceutical Business Overview
Table 129. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 130. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 131. Hengrui Pharmaceutical Recent Development
Table 132. Abiogen Pharma Company Details
Table 133. Abiogen Pharma Business Overview
Table 134. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 135. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 136. Abiogen Pharma Recent Development
Table 137. Drugs for Osteoarthritis Pain Market Trends
Table 138. Drugs for Osteoarthritis Pain Market Drivers
Table 139. Drugs for Osteoarthritis Pain Market Challenges
Table 140. Drugs for Osteoarthritis Pain Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Product Picture
Figure 2. Global Drugs for Osteoarthritis Pain Market Share by Type: 2024 VS 2031
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. External Features
Figure 6. Global Drugs for Osteoarthritis Pain Market Share by Application: 2024 VS 2031
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Drugs for Osteoarthritis Pain Report Years Considered
Figure 10. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Mid East & Africa Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Drugs for Osteoarthritis Pain Market Share by Players in 2024
Figure 19. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2024
Figure 21. North America Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 22. North America Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 23. Europe Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 24. Europe Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 25. China Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 26. China Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 27. Japan Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 29. Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 30. Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 31. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 32. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 33. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 34. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 35. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 37. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 38. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 39. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 40. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 41. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 42. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 43. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 44. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 45. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 46. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 47. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 48. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drugs for Osteoarthritis Pain Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drugs for Osteoarthritis Pain Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drugs for Osteoarthritis Pain Revenue Share by Region (2020-2025)
Table 6. Global Drugs for Osteoarthritis Pain Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drugs for Osteoarthritis Pain Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Table 10. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Table 15. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drugs for Osteoarthritis Pain Application
Table 18. Global Drugs for Osteoarthritis Pain Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drugs for Osteoarthritis Pain Market Share by Players (2020-2025)
Table 20. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Table 21. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served
Table 24. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
Table 25. Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 29. North America Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 37. China Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 41. Japan Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 43. Mid East & Africa Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 44. Mid East & Africa Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 45. Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 46. Mid East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Drugs for Osteoarthritis Pain Product
Table 50. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 55. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. GlaxoSmithKline Company Details
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 60. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Drugs for Osteoarthritis Pain Product
Table 65. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 70. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Osteoarthritis Pain Product
Table 75. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Drugs for Osteoarthritis Pain Product
Table 80. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Horizon Pharma Company Details
Table 83. Horizon Pharma Business Overview
Table 84. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 85. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 86. Horizon Pharma Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Drugs for Osteoarthritis Pain Product
Table 90. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Drugs for Osteoarthritis Pain Product
Table 95. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Daiichi Sankyo Company Details
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 100. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 101. Daiichi Sankyo Recent Development
Table 102. TEVA Company Details
Table 103. TEVA Business Overview
Table 104. TEVA Drugs for Osteoarthritis Pain Product
Table 105. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 106. TEVA Recent Development
Table 107. Almatica Pharma Company Details
Table 108. Almatica Pharma Business Overview
Table 109. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 110. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 111. Almatica Pharma Recent Development
Table 112. Astellas Pharma Company Details
Table 113. Astellas Pharma Business Overview
Table 114. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 115. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 116. Astellas Pharma Recent Development
Table 117. Tide Pharmaceutical Company Details
Table 118. Tide Pharmaceutical Business Overview
Table 119. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 120. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 121. Tide Pharmaceutical Recent Development
Table 122. Iroko Pharmaceuticals Company Details
Table 123. Iroko Pharmaceuticals Business Overview
Table 124. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 125. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 126. Iroko Pharmaceuticals Recent Development
Table 127. Hengrui Pharmaceutical Company Details
Table 128. Hengrui Pharmaceutical Business Overview
Table 129. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 130. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 131. Hengrui Pharmaceutical Recent Development
Table 132. Abiogen Pharma Company Details
Table 133. Abiogen Pharma Business Overview
Table 134. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 135. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 136. Abiogen Pharma Recent Development
Table 137. Drugs for Osteoarthritis Pain Market Trends
Table 138. Drugs for Osteoarthritis Pain Market Drivers
Table 139. Drugs for Osteoarthritis Pain Market Challenges
Table 140. Drugs for Osteoarthritis Pain Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Product Picture
Figure 2. Global Drugs for Osteoarthritis Pain Market Share by Type: 2024 VS 2031
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. External Features
Figure 6. Global Drugs for Osteoarthritis Pain Market Share by Application: 2024 VS 2031
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Drugs for Osteoarthritis Pain Report Years Considered
Figure 10. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Mid East & Africa Drugs for Osteoarthritis Pain Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Drugs for Osteoarthritis Pain Market Share by Players in 2024
Figure 19. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2024
Figure 21. North America Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 22. North America Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 23. Europe Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 24. Europe Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 25. China Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 26. China Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 27. Japan Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 29. Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2020-2025)
Figure 30. Mid East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2020-2025)
Figure 31. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 32. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 33. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 34. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 35. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 37. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 38. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 39. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 40. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 41. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 42. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 43. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 44. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 45. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 46. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 47. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 48. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232